General MedicationsINTRAVENOUSStandard
FRINDOVYX
CYCLOPHOSPHAMIDE
Standard Dose
1GM/2ML (500MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FRINDOVYX is listed in Drugs@FDA under application 210852 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 1GM/2ML (500MG/ML) Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-08-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview FRINDOVYX is listed in Drugs@FDA under application 210852 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 1GM/2ML (500MG/ML) Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-08-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.